glp 1 dementia study The EVOKE trials found that semaglutide, the GLP-1 drug behind several popular diabetes and weight loss medications, did not meaningfully slow cognitive decline in people with Alzheimer's disease. Despite these findings, scientists GLP-1 mimetics and cognition -

Topical is the more evidence-supported route, especially for skin endpoints

[26] Leigh portrays Schwarzenegger as obsessed with power and quotes him as saying, "I wanted to be part of the small percentage of people who were leaders, not the large mass of followers

Notably, MSC therapy preserved circulating regulatory T cells and stabilized inflammatory monocyte subsets, suggesting immunomodulatory effects

Releases WADAs 2026 Prohibited List is now in force The World Anti-Doping Agency (WADA) wishes to remind stakeholders that the 2026 List of Prohibited Substances and Methods (List) and the 2026 Monitoring Program are now in force as of today (1 January 2026)

Epithalon is explored for its influence on chromosomal end protection mechanisms, contributing to investigation of cellular stability pathways

-Arrestin-2 regulates the development of allergic asthma